Researchers successfully test coronavirus vaccine on mice, human trials to begin in next few months

indica News Service

The US scientists have said that a potential COVID-19 vaccine has been successfully tested on mice and  it will soon be tested on humans. The US scientists say that this vaccine which is delivered via a fingertip-sized patch induces an immune response which can prevent infection. 

A research team at the University of Pittsburgh School of Medicine has said that they have moved quickly in developing a potential vaccine for coronavirus which causes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).

Associate professor at Pittsburgh, Andrea Gambotto says: 

“These two viruses, which are closely related to SARS-CoV-2 (the new coronavirus causing the COVID-19 pandemic), teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus, we knew exactly where to fight this new virus.”

The vaccine which has been named PittCoVacc generated a surge of antibodies against the new coronavirus in less than 2 weeks. 

Is this coronavirus vaccine can have a lasting effect against the coronavirus infection?

There has been a word of caution though from the researchers who say that they are not sure that for how long the response against the Covid-19 will last after the use of the vaccine, however in the mice experiment it was found that the antibody created by the vaccine will remain effective for at least 1 year. 

Clinical trials of the vaccine on humans will start in the next few months.

Related posts